The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Ethic Inc.

Ethic Inc. increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,524 shares of the medical device company’s stock after purchasing an additional 517 shares during the quarter. Ethic Inc.’s holdings in Cooper Companies were worth $784,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of COO. Covestor Ltd grew its stake in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after buying an additional 120 shares during the period. Torray Investment Partners LLC increased its holdings in Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after purchasing an additional 132 shares in the last quarter. Mather Group LLC. raised its position in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after purchasing an additional 136 shares in the last quarter. Finally, Greenleaf Trust lifted its stake in shares of Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO stock opened at $80.47 on Thursday. The firm has a fifty day moving average of $80.13 and a two-hundred day moving average of $90.52. The firm has a market cap of $16.09 billion, a P/E ratio of 41.27, a P/E/G ratio of 2.25 and a beta of 1.08. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on COO shares. BNP Paribas upgraded Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Robert W. Baird decreased their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research note on Friday, March 7th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.